Evidence map›Paper›PMID 41540188›Full record

ArticleScientific reports2026

Yttrium-90 radioembolization for primary and metastatic liver tumors exhibiting arterial-phase hypovascularity.

Mira Malavia, Grace Eliason, Lucas A Eggers, Alex Arne, Katherine Marchak, James Hart, Jonathan Lindquist, Premal Trivedi, Leigh Casadaban

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mira MalaviaUniversity of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Grace EliasonDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Lucas A EggersDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Alex ArneDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Katherine MarchakDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
James HartDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Jonathan LindquistDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Premal TrivediDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Leigh CasadabanDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Leigh.Casadaban@CUAnschutz.edu.ORCID http://orcid.org/0000-0001-7388-7253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate dosimetry-derived tumor-to-perfused normal tissue ratio (T/N) and corresponding clinical outcomes of patients receiving yttrium-90 radioembolization with glass microspheres for tumors identified as hypovascular on arterial-phase cross-sectional imaging. Patients with hypovascular lesions undergoing

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsRadioembolization, TherapeuticYttrium RadioisotopesAgedAged, 80 and overCholangiocarcinomaFemaleHumansMaleMicrospheresMiddle AgedSingle Photon Emission Computed Tomography Computed TomographyTreatment OutcomeYttrium-90Yttrium Radioisotopes99mTc-MAAHepatocellular carcinomaHypovascularImaging responseIntrahepatic cholangiocarcinomaLiverRadioembolizationTreatmentTumorYttrium-90

Identifiers

PMID41540188
PMCPMC12867975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.